Cargando…

Baseline depressive symptoms as predictors of efficacy and tolerability of the treatment with duloxetine: a network analysis approach

INTRODUCTION: Depression is considered one of the most prevalent and burdensome mental disorders. Only 50–60% of patients respond to first-line treatment. Individuals with depression might benefit from personalized treatment, tailored to the individual needs of the patient. In this study, we aimed t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maciaszek, Julian, Pawłowski, Tomasz, Hadryś, Tomasz, Misiak, Błażej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312095/ https://www.ncbi.nlm.nih.gov/pubmed/37398593 http://dx.doi.org/10.3389/fpsyt.2023.1210289

Ejemplares similares

The Impact of the CYP2D6 and CYP1A2 Gene Polymorphisms on Response to Duloxetine in Patients with Major Depression
por: Maciaszek, Julian, et al.
Publicado: (2023)

A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine
por: Rodrigues-Amorim, Daniela, et al.
Publicado: (2020)

Coping Strategies and Psychopathological Responses Among Medical and Non-medical Professionals – a Cross-Sectional Online Survey
por: Ciułkowicz, Marta, et al.
Publicado: (2021)

Coping Styles, Mental Health, and the COVID-19 Quarantine: A Nationwide Survey in Poland
por: Kołodziejczyk, Agata, et al.
Publicado: (2021)

Does Mental Health Affect the Decision to Vaccinate Against SARS-CoV-2? A Cross-Sectional Nationwide Study Before the Vaccine Campaign
por: Maciaszek, Julian, et al.
Publicado: (2022)

Unknown Enemy and Psychopathological Responses: A Cross-Sectional Nationwide Study Assessing the Knowledge About COVID-19
por: Maciaszek, Julian, et al.
Publicado: (2021)

Reduction of Posttraumatic Stress Disorder (PTSD) Symptoms in PTSD and Major Depressive Disorder Comorbidity After Acute Hypoglycemia—A Case Report
por: Pawlowski, Tomasz, et al.
Publicado: (2019)

Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder
por: Muscatello, Maria Rosaria Anna, et al.
Publicado: (2019)

Stress, Allostatic Load, and Psychosis: One Step Forward in Research But Where to Go Next?
por: Misiak, Błażej
Publicado: (2020)

Effects of the interaction between PTSD and ADHD symptoms on the level of reporting psychotic-like experiences: findings from a non-clinical population
por: Gelner, Hanna, et al.
Publicado: (2023)

Changes in energy during treatment of depression: an analysis of duloxetine in double-blind placebo-controlled trials
por: Harada, E, et al.
Publicado: (2015)

Efficacy and Safety of Cordyceps militaris as an Adjuvant to Duloxetine in the Treatment of Insomnia in Patients With Depression: A 6-Week Double- Blind, Randomized, Placebo-Controlled Trial
por: Zhou, Jiaojiao, et al.
Publicado: (2021)

Class of 2020 in Poland: Students’ Mental Health during the COVID-19 Outbreak in an Academic Setting
por: Wieczorek, Tomasz, et al.
Publicado: (2021)

Efficacy of the Whole-Body Cryotherapy as Add-on Therapy to Pharmacological Treatment of Depression—A Randomized Controlled Trial
por: Rymaszewska, Joanna, et al.
Publicado: (2020)

Editorial: Endophenotypes for Schizophrenia and Mood Disorders: Implications from Genetic, Biochemical, Cognitive, Behavioral, and Neuroimaging Studies
por: Misiak, Błażej, et al.
Publicado: (2016)

Editorial: Peripheral Markers of Immune Response in Major Psychiatric Disorders: Where Are We Now and Where Do We Want to Be?
por: Misiak, Błazej, et al.
Publicado: (2019)

A Real-World, Prospective, Multicenter, Single-Arm Observational Study of Duloxetine in Patients With Major Depressive Disorder or Generalized Anxiety Disorder
por: Szekeres, Gyorgy, et al.
Publicado: (2021)

Psychopathological responses and face mask restrictions during the COVID-19 outbreak: Results from a nationwide survey
por: Szczesniak, Dorota, et al.
Publicado: (2020)

Depressive Symptom Network Associated With Comorbid Anxiety in Late-Life Depression
por: An, Min Ho, et al.
Publicado: (2019)

Depressive and Anxiety Symptoms Are Predictors of Seizure Recurrence in Adults With Newly Diagnosed Epilepsy
por: Zhong, Rui, et al.
Publicado: (2021)

Type D Personality and Big Five Personality Traits and the Risk of Breast Cancer: A Case-Control Study
por: Wojciechowska, Irena, et al.
Publicado: (2022)

Depressive Symptoms and PANSS Symptom Dimensions in Patients With Predominant Negative Symptom Schizophrenia: A Network Analysis
por: Demyttenaere, Koen, et al.
Publicado: (2022)

Mental Health of Medical and Non-Medical Professionals during the Peak of the COVID-19 Pandemic: A Cross-Sectional Nationwide Study
por: Maciaszek, Julian, et al.
Publicado: (2020)

Postpartum Depressive Symptoms and Their Selected Psychological Predictors in Breast-, Mixed and Formula-Feeding Mothers
por: Kossakowska, Karolina, et al.
Publicado: (2022)

From Emotional Intelligence to Self-Injuries: A Path Analysis in Adolescents With Conduct Disorder
por: Halicka-Masłowska, Joanna, et al.
Publicado: (2021)

The safety and tolerability of duloxetine in depressed elderly patients with and without medical comorbidity
por: Wise, T N, et al.
Publicado: (2007)

Disrupted Structural Brain Network Organization Behind Depressive Symptoms in Major Depressive Disorder
por: Liu, Jing, et al.
Publicado: (2020)

Mapping network connectivity between internet addiction and residual depressive symptoms in patients with depression
por: Cai, Hong, et al.
Publicado: (2022)

The Significance of Toll-Like Receptors in the Neuroimmunologic Background of Alcohol Dependence
por: Czerwińska-Błaszczyk, Agnieszka, et al.
Publicado: (2022)

Assessment of Appetite-Regulating Hormones Provides Further Evidence of Altered Adipoinsular Axis in Early Psychosis
por: Lis, Michał, et al.
Publicado: (2020)

Commentary: Parental Depressive Symptoms as a Predictor of Outcome in the Treatment of Child Internalizing and Externalizing Problems
por: Tahir, Talha, et al.
Publicado: (2019)

The Portrait of Cyberchondria—A Cross-Sectional Online Study on Factors Related to Health Anxiety and Cyberchondria in Polish Population during SARS-CoV-2 Pandemic
por: Ciułkowicz, Marta, et al.
Publicado: (2022)

Social Support Mediates the Association between Health Anxiety and Quality of Life: Findings from a Cross-Sectional Study
por: Ciułkowicz, Marta, et al.
Publicado: (2022)

The influence of duloxetine on detrusor overactivity in rats with depression induced by 13-cis-retinoic acid
por: Wróbel, Andrzej, et al.
Publicado: (2017)

Adverse Childhood Experiences and Neurocognition in Schizophrenia Spectrum Disorders: Age at First Exposure and Multiplicity Matter
por: Kasznia, Justyna, et al.
Publicado: (2021)

Network Analyses of Maternal Pre- and Post-Partum Symptoms of Depression and Anxiety
por: Phua, Desiree Y., et al.
Publicado: (2020)

The Efficacy, Safety, and Tolerability of Probiotics on Depression: Clinical Results From an Open-Label Pilot Study
por: Wallace, Caroline J. K., et al.
Publicado: (2021)

Common Brain Networks Between Major Depressive-Disorder Diagnosis and Symptoms of Depression That Are Validated for Independent Cohorts
por: Yamashita, Ayumu, et al.
Publicado: (2021)

Comparative Effect of Collaborative Care, Pain Medication, and Duloxetine in the Treatment of Major Depressive Disorder and Comorbid (Sub)Chronic Pain: Results of an Exploratory Randomized, Placebo-Controlled, Multicenter Trial (CC:PAINDIP)
por: de Heer, Eric W., et al.
Publicado: (2018)

Predictors of Treatment Response to an Internet-Delivered Intervention Targeting Residual Cognitive Symptoms After Major Depressive Disorder
por: Myklebost, Sunniva Brurok, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p9t5e7ldot1j8tfucop191ohnm